https://mobile.twitter.com/CoronaVirusUPDT/header_photo Corona virus in simple point and new guidline 2020 Coronavirus is RNA virus occurce bervious outbreak in 2002 and in 2012 In 2002 in china and called SARS In 2012 in sudia arabia called MERS Now in 2019 called COVID19 strat from seafood market in wuhan city and spread around the world today from wuhan city to each china and from china to each world Investigation Corona virus investigation by antibody and Rt PCR and CBC and X Ray And CT Incuption period 14 day transmission by hand contact mainly and by respirtory secrtion air droplets as T.b and rebulla is type four safety infection controle vaccine not available nowdue to chang in RNA very rapid some drug can effect but under clinical trial today this virus spread in many country about world is very very spread and pateint is dead from acut respirtory syndrom so x ray very imported old age is high risk to corona virus we undetectable about spread and treat and vaccine about world Due to high change in gentic code RNA Clincal picture of case presention Old age sever dysnea and dry couhp abdomenal pain and fever and rigor in some case and x_ray show penumonia and history from 2 weak contact infected person or travel infected area Thus case suscpected cirona case must be under to antibody and RTPCR to confirm case by Dr.Abdalncer_ahmad medical student in ASU cairo Libyan _tobruk city
Abstract and Figures The present study evaluated the incidence of breast cancer in Libya and described the clinicopathological and demographic features. These features were then compared with corresponding data from patients from sub-Saharan Africa (Nigeria) and Europe (Finland). The study consisted of 234 patients with breast carcinoma, admitted to the African Oncology Institute in Sabratha, Libya, during the years 2002-2006. The pathological features were collected from pathology reports, patient histories from hospital files and the Sabratha Cancer Registry. The demographic differences between the Libyan, Nigerian and Finnish populations were prominent. The mean age of breast cancer patients in Libya was 46 years which was almost identical to that of Nigeria, but much lower than that of Finland. The Libyan breast cancer incidence was evaluated as 18.8 per 100,000 female individuals. This incidence was markedly higher in Finland, but was also high in Nigeria. Libyan and Nigerian breast cancer is predominantly of premenopausal type and exhibits unfavorable characteristics such as high histological grade and stage, large tumor size and frequent lymph node metastases. However, the histological types and histopathological risk features show similar importance regarding survival as European breast cancer cases. Survival in Libya ranks between the rates of survival in Nigeria (lowest) and Finland (highest). In conclusion, in Libya and other African countries, premenopausal breast cancer is more common than postmenopausal breast cancer. However, the opposite is true for Europe. Population differences may be involved, as suggested by the known variation, in the distribution of genetic markers in these populations. Different types of environmental impacts, however, cannot be excluded. between 35 and 54 years old, in accordance with results of other studies, which have stated that breast cancer occurs a decade earlier compared to women of western countries; [17,18] and the mean age was 46 ± 11.7, which is not different from previous Libyan study. [19,20] Very young age <35 years represent 17% compared with study done in Egypt (8.19%). [21] Most of the cases were from Tripoli and AL-jabal Garbi and scanty of cases were from eastern region probably due to the presence of Benghazi medical center which is the referral center for that region. ... Tumor stage is considered as an important factor in local and distal recurrences, survival rate, and having an effective early diagnosis program. About half of the tumors in present study had been detected in Stage II, 27.1% in Stage IIB, which in agreement with the results reported by Boder et al., that revealed the majority of Libyan breast cancer patients were in Stages IIB and IIIA; [19] the current results showed 40.9% of cases were already at Stage III or IV at presentation and in accordance with the results presented by Yalazal et al., [30] as well as with Malvia et al. study results in India that showed 45.7% where in advanced stages. [18] Concerning the grade of tumor in the present study, results illustrated that 49.6% of tumors were in Grade 3 or 4 compared with study done by Engstrom et al. revealed that Of the 909 tumors, 12.9% were Grade 1, 53.7% Grade 2, and 33.4% Grade 3. [15] Tumors with both ER and PR negative have relatively poorer prognosis than cancers with either ER or PR positivity. ... Many studies on cancer incidence have been carried out in eastern and western regions of Libya to illustrate the extent of the problem. [6][7][8][15][16][17][18][19][20][21] We have attempted in this study to provide the incidence rate (using ASR) of different types of cancers in the southern region of Libya. The present study comprises 3 years (2016-2018) of data and provides a reasonably accurate description of cancer incidence in southern Libya and can contribute to a better understanding of the epidemiology of various cancers in this region and consequently provide a useful guide for the decision-makers to make effectual decisions about cancer control program and policies in Libya by Dr.Abdalncer_ahmad medical student in ASU cairo Libyan دcollection data from tobruk centr Salha Hussen abd-alrhman Amani Fathi Issa Almahdy Salama Bozaloot Asmaa Ahmida jad Allah Rokia mohammed elsherife Tagreed muftah ali Farah moustafa kahlile Sohila abdalhmeed othman
